• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳曲酮微球:体外释放及其对小鼠吗啡镇痛的影响。

Naltrexone microspheres: in vitro release and effect on morphine analgesia in mice.

作者信息

He G A, Hou H M, Liu X J

机构信息

National Pharmaceutical Engineering Research Center, Shanghai Institute of Pharmaceutical Industry, Shanghai 200437, China.

出版信息

Acta Pharmacol Sin. 2001 Jun;22(6):530-3.

PMID:11747760
Abstract

AIM

To study in vitro release and in vivo effect of four different types of sustained-release naltrexone microspheres on morphine analgesia.

METHODS

Release of naltrexone from four types of biodegradable microspheres was investigated by HPLC. Their antagonist effects on morphine analgesia were observed using mouse hot-plate procedure.

RESULTS

Poly latide-co-glycolide (PLGA) composition had a remarkable effect on naltrexone release from microspheres and its antagonism towards morphine analgesia. Two formulations of PLGA 50:50 formulation released more than 80 % of total naltrexone and lost their antagonism by 8 d. The PLGA 75:25 formulation with 20 % and 30 % drug loadings did not release 95 % of total drug and lose antagonism until 40 d and 30 d, respectively. Increasing the drug loading enhanced naltrexone release from microspheres and seemed to shorten the analgesic antagonistic effect of naltrexone.

CONCLUSION

Antagonism by naltrexone microspheres towards morphine analgesia correlates well with the drug release in vitro.

摘要

目的

研究四种不同类型的纳曲酮缓释微球的体外释放情况及对吗啡镇痛的体内作用。

方法

采用高效液相色谱法研究四种可生物降解微球中纳曲酮的释放情况。利用小鼠热板法观察它们对吗啡镇痛的拮抗作用。

结果

聚丙交酯-乙交酯(PLGA)组成对纳曲酮从微球中的释放及其对吗啡镇痛的拮抗作用有显著影响。两种PLGA 50:50配方释放了超过80%的总纳曲酮,且在8天时失去了拮抗作用。载药量为20%和30%的PLGA 75:25配方分别在40天和30天时才释放95%的总药物并失去拮抗作用。增加载药量可增强纳曲酮从微球中的释放,且似乎缩短了纳曲酮的镇痛拮抗作用。

结论

纳曲酮微球对吗啡镇痛的拮抗作用与体外药物释放密切相关。

相似文献

1
Naltrexone microspheres: in vitro release and effect on morphine analgesia in mice.纳曲酮微球:体外释放及其对小鼠吗啡镇痛的影响。
Acta Pharmacol Sin. 2001 Jun;22(6):530-3.
2
[Comparison of the antagonistic effects of 6 beta-naltrexol and naltrexone against morphine analgesia].[6β-纳曲醇与纳曲酮对吗啡镇痛拮抗作用的比较]
Yao Xue Xue Bao. 2003 Aug;38(8):578-81.
3
Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir.开发一种新型制剂,其包含分散在聚乳酸-乙醇酸共聚物-聚乙二醇-聚乳酸-乙醇酸共聚物(PLGA-PEG-PLGA)凝胶中的聚(d,l-丙交酯-乙交酯)微球,用于更昔洛韦的持续递送。
J Control Release. 2005 Nov 28;108(2-3):282-93. doi: 10.1016/j.jconrel.2005.09.002. Epub 2005 Oct 17.
4
Effect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres.丙交酯/乙交酯比例对更昔洛韦及其亲脂性前药(更昔洛韦单丁酸酯)从聚乳酸-羟基乙酸共聚物微球中的体外释放的影响。
Int J Pharm. 2007 Jun 29;338(1-2):133-41. doi: 10.1016/j.ijpharm.2007.01.038. Epub 2007 Feb 2.
5
Single- and multiple-dose pharmacokinetics of long-acting injectable naltrexone.长效注射用纳曲酮的单剂量和多剂量药代动力学
Alcohol Clin Exp Res. 2006 Mar;30(3):480-90. doi: 10.1111/j.1530-0277.2006.00052.x.
6
Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.工艺和配方参数对通过溶剂蒸发法制备的聚(d,l-丙交酯-共-乙交酯)微球的特性及内部形态的影响
Eur J Pharm Biopharm. 2008 Feb;68(2):214-23. doi: 10.1016/j.ejpb.2007.06.008. Epub 2007 Jun 15.
7
Development of drug delivery systems for use in treatment of narcotic addiction.用于治疗麻醉品成瘾的药物递送系统的开发。
NIDA Res Monogr. 1981;28:194-213.
8
Study on in vitro release patterns of fentanyl-loaded PLGA microspheres.载芬太尼聚乳酸-羟基乙酸共聚物微球的体外释放模式研究
J Microencapsul. 2003 Sep-Oct;20(5):569-79. doi: 10.1080/0265204031000148013.
9
Development of Chronomers tm for narcotic antagonists.用于麻醉拮抗剂的Chronomers tm的开发。
Natl Inst Drug Abuse Res Monogr Ser. 1976 Jan(4):39-42.
10
Development of injectable microcapsules for use in the treatment of narcotic addiction.
Natl Inst Drug Abuse Res Monogr Ser. 1975(4):19-20.

引用本文的文献

1
Safety and efficacy of an oxycodone vaccine: Addressing some of the unique considerations posed by opioid abuse.羟考酮疫苗的安全性与有效性:应对阿片类药物滥用引发的一些独特考量。
PLoS One. 2017 Dec 1;12(12):e0184876. doi: 10.1371/journal.pone.0184876. eCollection 2017.
2
In Vitro and In Vivo Evaluations of PLGA Microspheres Containing Nalmefene.含纳美芬的聚乳酸-羟基乙酸共聚物微球的体外和体内评价
PLoS One. 2015 May 4;10(5):e0125953. doi: 10.1371/journal.pone.0125953. eCollection 2015.